Member Login Area
Member Icon Login
Member Login
Member Icon Close
Inner Bubble 1
Inner Bubble 2
Inner Bubble 3
COD TEAM

Late Phase Clinical Trials

Veeda CR offers Clinical Trial Services through an established clinical trial site network spread across India.

Veeda has experience and expertise in handling clinical trials through different phases of clinical development ranging from Phase 1 to Phase 4 clinical trials. With the help of elaborate Investigator network across various therapeutic segments, experienced and insightful Project management team, established mechanisms for Site Management, Clinical Data Management, Clinical trial Management, Medical Writing, Quality Assurance service, Training and Regulatory Liaison activities, Veeda CR completed 4 Phase 2 Clinical trials, 2 Phase 3 clinical trials and 23 Patient based Pharmacokinetic trials till date. With a strong pipeline, Veeda CR is forging ahead as a reliable service provider in this segment.

Veeda offers an unparalleled Clinical trial service spanning all major states in India.

  • Till date we have completed 4 global multi-centric phase II clinical trials in Oncology, 2 phase III studies of injectable implants and 23 patient based PK trials in different therapeutic areas.
  • We have another 8 patient based PK trails in different level of execution in addition to 2 phase II studies each in oncology & cardiology therapeutic area
  • We have worked with more than 125 sites and recruited more than 1250 patients in the different trials.
Track Record:
  • Completed 29 Clinical trials (4 Phase II, 2 Phase III and 23 Patient PK trials).
  • Feasibilities: Patient PK (53) and Clinical Endpoint (46).
  • Total 10 trials (8 Patient PK + 2 Phase II) in different stages of execution.
Therapeutic Segments:
  • Oncology, Psychiatry, Dermatology, Rheumatology, Gastroenterology, Cardiology, Ophthalmology, ENT, Gynecology etc.
  • Extensive Investigators network and Experienced Project Management team
Trial Execution:
On time, Within budget and with applicable Regulatory Compliance

Rich experience in handling different types of studies over a wide range of therapeutic indications

Indication No. of Patients
Oncology  
- Chronic myeloid leukemia (CML) 200
- Metastatic breast Cancer 136
- Non-small cell lung cancer (NSCLC) 119
- Renal Cell Carcinoma (RCC) 88
- Colorectal Cancer 57
- Ovarian cancer 188
- Small cell lung cancer (SCLC) 32
Psychiatry  
- Schizophrenia 341
Rheumatology  
- Rheumatoid Arthritis 36
Bone Disease  
- Avascular Necrosis 14
- Articular cartilage defects of the Articulating joints 14
Other  
- HIV-1 48
- Psoriasis 9

Experience with patient based trials

Organization experience Dedicated Team
Competed Projects Combined Team Experience in Clinical Trials
- 4 global phase 11 clinical trials in Oncology More than 130 clinical trials that include
- 23 patient based PK clinical trials Around 25 global clinical trials
- 2 phase III clinical trials Around 30 clinical endpoint studies
Ongoing Projects 75 patient based PK clinical trials
-  10 Ongoing projects in different stage of execution.  

WHY PARTNER WITH VEEDA?

  • Veeda is an Independent CRO with 14 years of experience.
  • Veeda has conducted over 2400+ studies for USFDA/MHRA/EU
  • Veeda has over 900+ healthcare professional
  • Veeda has worked with over 200 pharmaceutical companies around the world ,and has Master Service Agreements with many of the top global pharmaceutical companies
  • Veeda has been audited 30 times since 2016 by the USFDA and has had no 483
  • We have over 600+ analytical methods
  • Quality is part of our DNA.
  • Experienced team to handle the criticalities and challenges of patient based studies
  • Scalable team approach
  • Proven track record of timely completion of patient recruitment even for rare indications like RCC and SCLC
  • Veeda is an Independent CRO with 13 years of experience.
  • Data base of prescreened experienced, GCP compliant Investigators with good tested recruiting potential
  • Worked with more than 125 Investigators’ sites in different therapeutic areas

Our exemplary regulatory track record

USFDA
33 times
Brazil ANVISA
7 times
WHO
5 times
UK MHRA
3 times
EU - AGES
1 times
South Africa - MCC
1 times
NPRA - Malaysia
4 times
DCGI
13 times